Search or choose
Find the right test or package.
RET is a proto-oncogene that encodes a receptor tyrosine kinase. Mutations in the RET gene can lead to the development of certain cancers, particularly medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). RET gene mutation testing...
RET is a proto-oncogene that encodes a receptor tyrosine kinase. Mutations in the RET gene can lead to the development of certain cancers, particularly medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). RET gene mutatio...
RET is a proto-oncogene that encodes a receptor tyrosine kinase. Mutations in the RET gene can lead to the development of certain cancers, particularly medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). RET gene mutation testing helps diagnose and classify these conditions. It's also used for risk assessment in families with a history of these conditions, allowing for early intervention and personalized medical management. Additionally, targeted therapies may be considered for some in...
RET gene mutation includes RET gene mutation.
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.